These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14600407)

  • 1. Decreased cyclosporin A concentrations in the absorption phase using microemulsion preconcentrate formulation in rats with cisplatin-induced acute renal failure.
    Igarashi T; Yano I; Saito H; Inui K
    Biol Pharm Bull; 2003 Nov; 26(11):1591-5. PubMed ID: 14600407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect absorption behavior of cyclosporin a in gentamicin-induced acute renal failure in rats.
    Shibata N; Morimoto J; Hoshino N; Minouchi T; Yamaji A
    Ren Fail; 2000 Mar; 22(2):181-94. PubMed ID: 10803762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of glycerol-induced acute renal failure on the pharmacokinetics of cyclosporin in rats.
    Shibata N; Ohmae T; Hoshino N; Minouchi T; Yamaji A
    J Pharm Pharmacol; 1999 Apr; 51(4):397-404. PubMed ID: 10385211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.
    Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K
    Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
    Noble S; Markham A
    Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of cyclosporin from conventional and new microemulsion oral formulations in liver transplant recipients with external biliary diversion.
    Trull AK; Tan KK; Tan L; Alexander GJ; Jamieson NV
    Br J Clin Pharmacol; 1995 Jun; 39(6):627-31. PubMed ID: 7654480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclosporin on the pharmacokinetics of propranolol after intravenous and oral administration to control rats and to rats with uranyl nitrate-induced acute renal failure.
    Lee YH; Ku YS
    J Pharm Pharmacol; 1999 Oct; 51(10):1149-54. PubMed ID: 10579686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
    Coukell AJ; Plosker GL
    Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral adsorbent AST-120 on cyclosporin absorption in rats.
    Takemoto M; Tsuchida M; Konishi M; Suga A; Iojima K; Naito K
    J Pharm Pharmacol; 1997 Jul; 49(7):657-60. PubMed ID: 9255707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis.
    Tan KK; Trull AK; Uttridge JA; Wallwork J
    Eur J Clin Pharmacol; 1995; 48(3-4):285-9. PubMed ID: 7589056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pharmacokinetic interaction between cyclosporin A and probucol in rats.
    Jiko M; Yano I; Wakasugi H; Saito H; Inui K
    Pharm Res; 2002 Sep; 19(9):1362-7. PubMed ID: 12403074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.
    Yamaguchi H; Yano I; Saito H; Inui K
    Pharm Res; 2004 Feb; 21(2):330-8. PubMed ID: 15032316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new microemulsion formulation of cyclosporin: pharmacokinetic and clinical features.
    Friman S; Bäckman L
    Clin Pharmacokinet; 1996 Mar; 30(3):181-93. PubMed ID: 8882300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
    Izuwa Y; Kusaba J; Horiuchi M; Aiba T; Kawasaki H; Kurosaki Y
    Drug Metab Pharmacokinet; 2009; 24(5):451-7. PubMed ID: 19881257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and biliary excretion of bromosulphophthalein, [3H]-ouabain and [3H]-taurocholic acid in rats with glycerol-induced acute renal failure.
    Bowmer CJ; Yates MS
    Br J Pharmacol; 1984 Nov; 83(3):773-82. PubMed ID: 6509262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation.
    Dunn CJ; Wagstaff AJ; Perry CM; Plosker GL; Goa KL
    Drugs; 2001; 61(13):1957-2016. PubMed ID: 11708766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoral (cyclosporin) in dermatology: technical aspects.
    Smith SG
    Br J Dermatol; 1996 Sep; 135 Suppl 48():2-4. PubMed ID: 8881896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction.
    Okabe H; Yano I; Hashimoto Y; Saito H; Inui K
    J Pharm Pharmacol; 2002 Jan; 54(1):65-70. PubMed ID: 11829131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states.
    Shibata N; Shimakawa H; Minouchi T; Yamaji A
    Biol Pharm Bull; 1993 Nov; 16(11):1130-5. PubMed ID: 8312870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.